Ultraviolet B regulation of transcription factor families: Roles of nuclear factor-kappa B (NF-κB) and activator protein-1 (AP-1) in UVB-induced skin carcinogenesis

Current Cancer Drug Targets

Volumn 7, Issue 4, 2007, Pages 325-334

  Cooper, S J ^a   Bowden, G T ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Activator Protein 1 (AP 1); Nuclear Factor kappa B (NF B); Photochemoprevention; Transcription factor families; Ultraviolet B radiation (UVB); UV response genes

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLSALICYLIC ACID; ALITRETINOIN; CAFFEINE; CALCITRIOL; CURCUMIN; CYANIDIN 3 GLUCOSIDE; HERBACEOUS AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PARTHENOLIDE; PERILLYL ALCOHOL; POLYPHENOL; RESVERATROL; RETINOIC ACID; SB 242235; SILIBININ; SULFORAPHANE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE;

CANCER INCIDENCE; CANCER MODEL; CANCER PREVENTION; CELL DAMAGE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; DNA DAMAGE; DRUG EFFECT; DRUG TARGETING; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; NONHUMAN; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN FUNCTION; RADIATION EXPOSURE; REGULATORY MECHANISM; REVIEW; SKIN CANCER; SKIN CARCINOGENESIS; SUN EXPOSURE; ULTRAVIOLET B RADIATION;

CELL DIFFERENTIATION; CELL PROLIFERATION; DNA DAMAGE; HUMANS; NEOPLASMS, RADIATION-INDUCED; NF-KAPPA B; SKIN NEOPLASMS; TRANSCRIPTION FACTOR AP-1; ULTRAVIOLET RAYS;

EID: 34249808829     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/156800907780809714     Document Type: Review

References (123)

1. Johnson, T. M.; Dolan, O. M.; Hamilton, T. A.; Lu, M. C.; Swanson, N. A.; Lowe, L. Clinical and histologic trends of melanoma. J. Am. Acad. Dermatol. 1998, 38 (5 Pt 1), 681-686.
2. Kwa, R. E.; Campana, K.; Moy, R. L. Biology of cutaneous squamous cell carcinoma. J. Am. Acad. Dermatol. 1992, 26 (1), 1-26.
3. Ting, W. W.; Vest, C. D.; Sontheimer, R. Practical and experimental consideration of sun protection in dermatology. Int. J. Dermatol. 2003, 42 (7), 505-13.
4. Shae, C. R.; Parrish, J. A. Nonionizing radation and the skin. In Physiology, biochemistry and molecular biology of the skin; G. LA, Editor; 1991, Oxford University Press: New York. pp. 910-927.
5. Cole, C. A.; Forbes, P. D.; Davies, R. E. An action spectrum for UV photocarcinogenesis. Photochem. Photobiol. 1986, 43 (3), 275-284.
6. de Gruijl, F. R.; Sterenborg, H. J.; Forbes, P. D.; Davies, R. E.; Cole, C.; Kelfkens, G.; van Weelden, H.; Slaper, H.; van der Leun, J. C. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice. Cancer Res. 1993, 53 (1), 53-60.
7. Matsui, M. S.a.D., V. A. Photocarcinogenesis by ultraviolet A and B; In Skin Cancer: Mechanisms and Human Relevance; H. Mukhtar, Editor; 1995, CRC Press: Boca Raton. pp. 21-30.
8. Willis, I.; Menter, J. M.; Whyte, H. J. The rapid induction of cancers in the hairless mouse utilizing the principle of photoaugmentation. J. Invest. Dermatol. 1981, 76 (5), 404-408.
9. Strickland, P. T. Photocarcinogenesis by near-ultraviolet (UVA) radiation in Sencar mice. J. Invest. Dermatol. 1986, 87 (2), 272-275.
10. Pfeifer, G. P.; You, Y. H.; Besaratinia, A. Mutations induced by ultraviolet light. Mutat. Res. 2005, 571(1-2), 19-31.
11. You, Y. H.; Lee, D. H.; Yoon, J. H.; Nakajima, S.; Yasui, A.; Pfeifer, G.P. Cyclobutane pyrimidine dimers are responsible for the vast majority of mutations induced by UVB irradiation in mammalian cells. J. Biol. Chem. 2001, 276(48), 44688-44694.
12. Soehnge, H.; Ouhtit, A.; Ananthaswamy, O. N. Mechanisms of induction of skin cancer by UV radiation. Front. Biosci. 1997, 2, d538-d551.
13. Matsumura, Y.; Ananthaswamy, H. N. Toxic effects of ultraviolet radiation on the skin. Toxicol. Appl. Pharmacol. 2004, 195(3), 298-308.
14. Basset-Seguin, N.; Moles, J. P.; Mils, V.; Dereure, O.; Guilhou, J. J. TP53 tumor suppressor gene and skin carcinogenesis. J. Invest. Dermatol. 1994, 103(5 Suppl.), 102S-106S.
15. Ziegler, A.; Jonason, A. S.; Leffell, D. J.; Simon, J. A.; Sharma, H. W.; Kimmelman, J.; Remington, L.; Jacks, T.; Brash, D. E. Sunburn and p53 in the onset of skin cancer. Nature 1994, 372(6508), 773-776.
16. Tornaletti, S.; Rozek, D.; Pfeifer, G. P. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer. Oncogene 1993, 8(8), 2051-2057.
17. Bachelor, M. A.; Bowden, G. T. UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin. Cancer Biol. 2004, 14 (2), 131-138.
18. Li, D.; Turi, T. G.; Schuck, A.; Freedberg, I. M.; Khitrov, G.; Blumenberg, M. Rays and arrays: the transcriptional program in the response of human epidermal keratinocytes to UVB illumination. FASEB J. 2001, 15 (13), 2533-2535.
19. Bender, K.; Blattner, C.; Knebel, A.; Iordanov, M.; Herrlich, P.; Rahmsdorf, H. J. UV-induced signal transduction. J. Photochem. Photobiol. B 1997, 37 (1-2), 1-17.
20. Janssens, S.; Tinel, A.; Lippens, S.; Tschopp, J. PIDD mediates NF-kappaB activation in response to DNA damage. Cell 2005, 123(6), 1079-1092.
21. Gilmore, T. D.; Koedood, M.; Piffat, K. A.; White, D. W. Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 1996, 13 (7), 1367-1378.
22. Shaulian, E.; Karin, M. AP-1 in cell proliferation and survival. Oncogene 2001, 20 (19), 2390-2400.
23. Li, J. J.; Westergaard, C.; Ghosh, P.; Colburn, N. H. Inhibitors of both nuclear factor-kappaB and activator protein-1 activation block the neoplastic transformation response. Cancer Res. 1997, 57 (16), 3569-3576.
24. Wang, J.; Ouyang, W.; Li, J.; Wei, L.; Ma, Q.; Zhang, Z.; Tong, Q.; He, J.; Huang, C. Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation. Cancer Res. 2005, 65 (15), 6601-11.
25. Lu, Y. P.; Lou, Y. R.; Yen, P.; Mitchell, D.; Huang, M. T.; Conney, A. H. Time course for early adaptive responses to ultraviolet B light in the epidermis of SKH-1 mice. Cancer Res. 1999, 59 (18), 4591-4602.
26. Bachelor, M. A.; Cooper, S. J.; Sikorski, E. T.; Bowden, G. T. Inhibition of p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase decreases UVB-induced activator protein-1 and cyclooxygenase-2 in a SKH-1 hairless mouse model. Mol. Cancer Res. 2005, 3(2), 90-99.
27. Buckman, S. Y.; Gresham, A.; Hale, P.; Hruza, G.; Anast, J.; Masferrer, J.; Pentland, A. P. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer. Carcinogenesis 1998, 19 (5), 723-729.
28. Berton, T. R.; Pavone, A.; Fischer, S.M. Ultraviolet-B irradiation alters the cell cycle machinery in murine epidermis in vivo. J. Invest. Dermatol. 2001, 117(5), 1171-1178.
29. Lee, J. K.; Kim, J. H.; Nam, K. T.; Lee, S. H. Molecular events associated with apoptosis and proliferation induced by ultraviolet-B radiation in the skin of hairless mice. J. Dermatol. Sci. 2003, 32 (3), 171-179.
30. An, K. P.; Athar, M.; Tang, X.; Katiyar, S. K.; Russo, J.; Beech, J.; Aszterbaum, M.; Kopelovich, L.; Epstein, E. H., Jr.; Mukhtar, H.; Bickers, D. R. Cyclooxygenase-2 expression in murine and human nonmelanoma skin cancers: implications for therapeutic approaches. Photochem. Photobiol. 2002, 76 (1), 73-80.
31. Kim, A. L.; Athar, M.; Bickers, D. R.; Gautier, J. Stage-specific alterations of cyclin expression during UVB-induced murine skin tumor development. Photochem. Photobiol. 2002, 75 (1), 58-67.
32. Robles, A. I.; Rodriguez-Puebla, M. L.; Glick, A. B.; Trempus, C.; Hansen, L.; Sicinski, P.; Tennant, R. W.; Weinberg, R. A.; Yuspa, S. H.; Conti, C. J. Reduced skin tumor development in cyclin D1-deficient mice highlights the oncogenic ras pathway in vivo. Genes Dev. 1998, 12 (16), 2469-2474.
33. Cooper, S. J.; MacGowan, J.; Ranger-Moore, J.; Young, M. R.; Colburn, N. H.; Bowden, G. T. Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol. Cancer Res. 2003, 1(11), 848-854.
34. Sauter, E. R.; Nesbit, M.; Litwin, S.; Klein-Szanto, A. J.; Cheffetz, S.; Herlyn, M. Antisense cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res. 1999, 59 (19), 4876-4881.
35. Rundhaug, J. E.; Hawkins, K. A.; Pavone, A.; Gaddis, S.; Kil, H.; Klein, R. D.; Berton, T. R.; McCauley, E.; Johnson, D. G.; Lubet, R. A.; Fischer, S. M.; Aldaz, C. M. SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Mol. Carcinog. 2005, 42 (1), 40-52.
36. Liu, H.; Deng, X.; Shyu, Y. J.; Li, J. J.; Taparowsky, E. J.; Hu, C. D. Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization. EMBO J. 2006, 25 (5), 1058-1069.
37. Steinmuller, L.; Cibelli, G.; Moll, J. R.; Vinson, C.; Thiel, G. Regulation and composition of activator protein 1 (AP-1) transcription factors controlling collagenase and c-Jun promoter activities. Biochem. J. 2001, 360(Pt 3), 599-607.
38. Bernstein, L. R.; Colburn, N. H. AP1/jun function is differentially induced in promotion-sensitive and resistant JB6 cells. Science 1989, 244(4904), 566-569.
39. Domann, F. E., Jr.; Levy, J. P.; Finch, J. S.; Bowden, G. T. Constitutive AP-1 DNA binding and transactivating ability of malignant but not benign mouse epidermal cells. Mol. Carcinog. 1994, 9(2), 61-66.
40. Young, M. R.; Li, J. J.; Rincon, M.; Flavell, R. A.; Sathyanarayana, B. K.; Hunziker, R.; Colburn, N. Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion. Proc. Natl. Acad. Sci. USA 1999, 96 (17), 9827-9832.
41. Thompson, E. J.; MacGowan, J.; Young, M. R.; Colburn, N.; Bowden, G. T. A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion. Cancer Res. 2002, 62 (11), 3044-3047.
42. Chen, W.; Borchers, A. H.; Dong, Z.; Powell, M. B.; Bowden, G. T. UVB irradiation-induced activator protein-1 activation correlates with increased c-fos gene expression in a human keratinocyte cell line. J. Biol. Chem. 1998, 273(48), 32176-32181.
43. Chen, W.; Bowden, G. T. Activation of p38 MAP kinase and ERK are required for ultraviolet-B induced c-fos gene expression in human keratinocytes. Oncogene 1999, 18 (52), 7469-7476.
44. Ramos, M. C.; Steinbrenner, H.; Stuhlmann, D.; Sies, H.; Brenneisen, P. Induction of MMP-10 and MMP-1 in a squamous cell carcinoma cell line by ultraviolet radiation. Biol. Chem. 2004, 385(1), 75-86.
45. Fisher, G. J.; Datta, S. C.; Talwar, H. S.; Wang, Z. Q.; Varani, J.; Kang, S.; Voorhees, J. J. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996, 379(6563), 335-339.
46. Zenz, R.; Wagner, E. F. Jun signalling in the epidermis: From developmental defects to psoriasis and skin tumors. Int. J. Biochem. Cell Biol. 2006, 38 (7), 1043-1049.
47. Bowden, G. T. Prevention of non-melanoma skin cancer by targeting ultraviolet-B-light signalling. Nat. Rev. Cancer 2004, 4(1), 23-35.
48. Kim, A. L.; Labasi, J. M.; Zhu, Y.; Tang, X.; McClure, K.; Gabel, C. A.; Athar, M.; Bickers, D. R. Role of p38 MAPK in UVB-induced inflammatory responses in the skin of SKH-1 hairless mice. J. Invest. Dermatol. 2005, 124(6), 1318-1325.
49. Ghosh, S.; May, M. J.; Kopp, E. B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Ann. Rev. Immunol. 1998, 16 , 225-260.
50. Baeuerle, P. A.; Baltimore, D. NF-kappa B: ten years after. Cell 1996, 87 (1), 13-20.
51. Bell, S.; Degitz, K.; Quirling, M.; Jilg, N.; Page, S.; Brand, K. Involvement of NF-kappaB signalling in skin physiology and disease. Cell Signal. 2003, 15 (1), 1-7.
52. Karin, M.; Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu. Rev. Immunol. 2000, 18 , 621-663.
53. Livolsi, A.; Busuttil, V.; Imbert, V.; Abraham, R. T.; Peyron, J. F. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases. Eur. J. Biochem. 2001, 268(5), 1508-1515.
54. Solan, N. J.; Miyoshi, H.; Carmona, E. M.; Bren, G. D.; Paya, C. V. RelB cellular regulation and transcriptional activity are regulated by p100. J. Biol. Chem. 2002, 277(2), 1405-1418.
55. Cooper, S.; Ranger-Moore, J.; Bowden, T. G. Differential inhibition of UVB-induced AP-1 and NF-kappaB transactivation by components of the jun bZIP domain. Mol. Carcinog. 2005, 43 (2), 108-116.
56. Imbert, V.; Rupec, R. A.; Livolsi, A.; Pahl, H. L.; Traenckner, E. B.; Mueller-Dieckmann, C.; Farahifar, D.; Rossi, B.; Auberger, P.; Baeuerle, P. A.; Peyron, J. F. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa Balpha. Cell 1996, 86 (5), 787-798.
57. Budunova, I. V.; Perez, P.; Vaden, V. R.; Spiegelman, V. S.; Slaga, T. J.; Jorcano, J. L. Increased expression of p50-NF-kappaB and constitutive activation of NF-kappaB transcription factors during mouse skin carcinogenesis. Oncogene 1999, 18 (52), 7423-7431.
58. Hsu, T. C.; Nair, R.; Tulsian, P.; Camalier, C. E.; Hegamyer, G. A.; Young, M. R.; Colburn, N. H. Transformation nonresponsive cells owe their resistance to lack of p65/nuclear factor-kappaB activation. Cancer Res. 2001, 61 (10), 4160-4168.
59. Kobielak, A.; Fuchs, E. Links between alpha-catenin, NF-kappaB, and squamous cell carcinoma in skin. Proc. Natl. Acad. Sci. USA 2006, 103(7), 2322-2327.
60. Karin, M.; Greten, F. R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5(10), 749-759.
61. Abeyama, K.; Eng, W.; Jester, J. V.; Vink, A. A.; Edelbaum, D.; Cockerell, C. J.; Bergstresser, P. R.; Takashima, A. A role for NF-kappaB-dependent gene transactivation in sunburn. J. Clin. Invest. 2000, 105(12), 1751-1759.
62. Yokoyama, S.; Nakano, H.; Yamazaki, T.; Tamai, K.; Hanada, K.; Takahashi, G. Enhancement of ultraviolet-induced apoptosis by NF-kappaB decoy oligonucleotides. Br. J. Dermatol. 2005, 153(Suppl. 2), 47-51.
63. Seitz, C. S.; Lin, Q.; Deng, H.; Khavari, P. A. Alterations in NF-kappaB function in transgenic epithelial tissue demonstrate a growth inhibitory role for NF-kappaB. Proc. Natl. Acad. Sci. USA 1998, 95 (5), 2307-2312.
64. Seitz, C. S.; Freiberg, R. A.; Hinata, K.; Khavari, P. A. NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest. 2000, 105(3), 253-260.
65. van Hogerlinden, M.; Rozell, B. L.; Ahrlund-Richter, L.; Toftgard, R. Squamous cell carcinomas and increased apoptosis in skin with inhibited Rel/nuclear factor-kappaB signaling. Cancer Res. 1999, 59 (14), 3299-3303.
66. van Hogerlinden, M.; Auer, G.; Toftgard, R. Inhibition of Rel/Nuclear Factor-kappaB signaling in skin results in defective DNA damage-induced cell cycle arrest and Ha-ras- and p53-independent tumor development. Oncogene 2002, 21 (32), 4969-4977.
67. Dajee, M.; Lazarov, M.; Zhang, J. Y.; Cai, T.; Green, C. L.; Russell, A. J.; Marinkovich, M. P.; Tao, S.; Lin, Q.; Kubo, Y.; Khavari, P. A. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003, 421(6923), 639-643.
68. Beg, A. A.; Sha, W. C.; Bronson, R. T.; Ghosh, S.; Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995, 376(6536), 167-170.
69. Beg, A. A.; Sha, W. C.; Bronson, R. T.; Baltimore, D. Constitutive NF-kappa B activation, enhanced granulopoiesis, and neonatal lethality in I kappa B alpha-deficient mice. Genes Dev. 1995, 9(22), 2736-2746.
70. Tanaka, M.; Fuentes, M. E.; Yamaguchi, K.; Durnin, M. H.; Dalrymple, S. A.; Hardy, K. L.; Goeddel, D. V. Embryonic lethality, liver degeneration, and impaired NF-kappa B activation in IKK-beta-deficient mice. Immunity 1999, 10 (4), 421-429.
71. Zhang, J. Y.; Green, C. L.; Tao, S.; Khavari, P. A. NF-kappaB RelA opposes epidermal proliferation driven by TNFR1 and JNK. Genes Dev. 2004, 18 (1), 17-22.
72. Gugasyan, R.; Voss, A.; Varigos, G.; Thomas, T.; Grumont, R. J.; Kaur, P.; Grigoriadis, G.; Gerondakis, S. The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Mol. Cell Biol. 2004, 24 (13), 5733-5745.
73. Hsu, T. C.; Young, M. R.; Cmarik, J.; Colburn, N. H. Activator protein 1 (AP-1)- and nuclear factor kappaB (NF-kappaB)-dependent transcriptional events in carcinogenesis. Free Radic. Biol. Med. 2000, 28 (9), 1338-1348.
74. Stein, B.; Baldwin, A. S., Jr.; Ballard, D. W.; Greene, W. C.; Angel, P.; Herrlich, P. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 1993, 12 (10), 3879-3891.
75. Hu, C. D.; Chinenov, Y.; Kerppola, T. K. Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 2002, 9(4), 789-798.
76. Rahmani, M.; Peron, P.; Weitzman, J.; Bakiri, L.; Lardeux, B.; Bernuau, D. Functional cooperation between JunD and NF-kappaB in rat hepatocytes. Oncogene 2001, 20 (37), 5132-5142.
77. Li, J. J.; Cao, Y.; Young, M. R.; Colburn, N. H. Induced expression of dominant-negative c-jun downregulates NFkappaB and AP-1 target genes and suppresses tumor phenotype in human keratinocytes. Mol. Carcinog. 2000, 29 (3), 159-169.
78. Thompson, E. J.; Gupta, A.; Stratton, M. S.; Bowden, G. T. Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activation. Mol. Carcinog. 2002, 35 (4), 157-162.
79. Nagasaki, K.; Schem, C.; von Kaisenberg, C.; Biallek, M.; Rosel, F.; Jonat, W.; Maass, N. Leucine-zipper protein, LDOC1, inhibits NF-kappaB activation and sensitizes pancreatic cancer cells to apoptosis. Int. J. Cancer 2003, 105(4), 454-458.
80. Hu, J.; Nakano, H.; Sakurai, H.; Colburn, N. H. Insufficient p65 phosphorylation at S536 specifically contributes to the lack of NF-kappaB activation and transformation in resistant JB6 cells. Carcinogenesis 2004, 25 (10), 1991-2003.
81. Huang, C.; Li, J.; Ding, M.; Wang, L.; Shi, X.; Castranova, V.; Vallyathan, V.; Ju, G.; Costa, M. Arsenic-induced NFkappaB transactivation through Erks- and JNKs-dependent pathways in mouse epidermal JB6 cells. Mol. Cell. Biochem. 2001, 222(1-2), 29-34.
82. Ma, C.; Wang, J.; Luo, J. Activation of nuclear factor kappa B by diesel exhaust particles in mouse epidermal cells through phosphatidylinositol 3-kinase/Akt signaling pathway. Biochem. Pharmacol. 2004, 67 (10), 1975-1983.
83. Dhawan, P.; Singh, A. B.; Ellis, D. L.; Richmond, A. Constitutive activation of Akt/protein kinase B in melanoma leads to up-regulation of nuclear factor-kappaB and tumor progression. Cancer Res. 2002, 62 (24), 7335-7342.
84. Kane, L. P.; Mollenauer, M. N.; Xu, Z.; Turck, C. W.; Weiss, A. Akt-dependent phosphorylation specifically regulates Cot induction of NF-kappaB-dependent transcription. Mol. Cell Biol. 2002, 22 (16), 5962-5974.
85. Feng, R.; Lu, Y.; Bowman, L. L.; Qian, Y.; Castranova, V.; Ding, M. Inhibition of activator protein-1, NF-kappaB, and MAPKs and induction of phase 2 detoxifying enzyme activity by chlorogenic acid. J. Biol. Chem. 2005, 280(30), 27888-27895.
86. Huang, Q.; Shen, H. M.; Ong, C. N. Inhibitory effect of emodin on tumor invasion through suppression of activator protein-1 and nuclear factor-kappaB. Biochem. Pharmacol. 2004, 68 (2), 361-371.
87. Baade, P. D.; Balanda, K. P.; Lowe, J. B. Changes in skin protection behaviors, attitudes, and sunburn: in a population with the highest incidence of skin cancer in the world. Cancer Detect. Prev. 1996, 20 (6), 566-575.
88. Naylor, M. F.; Boyd, A.; Smith, D. W.; Cameron, G. S.; Hubbard, D.; Neldner, K. H. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch. Dermatol. 1995, 131(2), 170-175.
89. Harvey, I.; Frankel, S.; Marks, R.; Shalom, D.; Nolan-Farrell, M. Nonmelanoma skin cancer and solar keratoses II analytical results of the South Wales Skin Cancer Study. Br. J. Cancer 1996, 74 (8), 1308-1312.
90. Wolf, P.; Donawho, C. K.; Kripke, M. L. Effect of sunscreens on UV radiation-induced enhancement of melanoma growth in mice. J. Natl. Cancer Inst. 1994, 86 (2), 99-105.
91. Hursting, S. D.; Slaga, T. J.; Fischer, S. M.; DiGiovanni, J.; Phang, J. M. Mechanism-based cancer prevention approaches: targets, examples, and the use of transgenic mice. J. Natl. Cancer Inst. 1999, 91 (3), 215-225.
92. Afaq, F.; Adhami, V. M.; Mukhtar, H. Photochemoprevention of ultraviolet B signaling and photocarcinogenesis. Mutat. Res. 2005, 571(1-2), 153-173.
93. Huang, C.; Ma, W. Y.; Hanenberger, D.; Cleary, M. P.; Bowden, G. T.; Dong, Z. Inhibition of ultraviolet B-induced activator protein-1 (AP-1) activity by aspirin in AP-1-luciferase transgenic mice. J. Biol. Chem. 1997, 272(42), 26325-26331.
94. Bair, W. B., 3rd; Hart, N.; Einspahr, J.; Liu, G.; Dong, Z.; Alberts, D.; Bowden, G.T. Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis. Cancer Epidemiol. Biomarkers Prev. 2002, 11 (12), 1645-1652.
95. Barthelman, M.; Chen, W.; Gensler, H. L.; Huang, C.; Dong, Z.; Bowden, G. T. Inhibitory effects of perillyl alcohol on UVB-induced murine skin cancer and AP-1 transactivation. Cancer Res. 1998, 58 (4), 711-716.
96. Darwiche, N.; Bazzi, H.; El-Touni, L.; Abou-Lteif, G.; Doueiri, R.; Hatoum, A.; Maalouf, S.; Gali-Muhtasib, H. Regulation of ultraviolet B radiation-mediated activation of AP1 signaling by retinoids in primary keratinocytes. Radiat. Res. 2005, 163(3), 296-306.
97. Cho, J. W.; Park, K.; Kweon, G. R.; Jang, B. C.; Baek, W. K.; Suh, M. H.; Kim, C. W.; Lee, K. S.; Suh, S. I. Curcumin inhibits the expression of COX-2 in UVB-irradiated human keratinocytes (HaCaT) by inhibiting activation of AP-1: p38 MAP kinase and JNK as potential upstream targets. Exp. Mol. Med. 2005, 37 (3), 186-192.
98. Won, Y. K.; Ong, C. N.; Shi, X.; Shen, H. M. Chemopreventive activity of parthenolide against UVB-induced skin cancer and its mechanisms. Carcinogenesis 2004, 25 (8), 1449-1458.
99. Lu, Y. P.; Lou, Y. R.; Lin, Y.; Shih, W. J.; Huang, M. T.; Yang, C. S.; Conney, A. H. Inhibitory effects of orally administered green tea, black tea, and caffeine on skin carcinogenesis in mice previously treated with ultraviolet B light (high-risk mice): relationship to decreased tissue fat. Cancer Res. 2001, 61 (13), 5002-5009.
100. Ahmad, N.; Mukhtar, H. Green tea polyphenols and cancer: biologic mechanisms and practical implications. Nutr. Rev. 1999, 57 (3), 78-83.
101. Wang, Z. Y.; Agarwal, R.; Bickers, D. R.; Mukhtar, H. Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 1991, 12 (8), 1527-1530.
102. Lu, Y. P.; Lou, Y. R.; Liao, J.; Xie, J. G.; Peng, Q. Y.; Yang, C. S.; Conney, A. H. Administration of green tea or caffeine enhances the disappearance of UVB-induced patches of mutant p53 positive epidermal cells in SKH-1 mice. Carcinogenesis 2005, 26 (8), 1465-1472.
103. Kramata, P.; Lu, Y. P.; Lou, Y. R.; Cohen, J. L.; Olcha, M.; Liu, S.; Conney, A. H. Effect of administration of caffeine or green tea on the mutation profile in the p53 gene in early mutant p53-positive patches of epidermal cells induced by chronic UVB-irradiation of hairless SKH-1 mice. Carcinogenesis 2005, 26 (11), 1965-1974.
104. Afaq, F.; Ahmad, N.; Mukhtar, H. Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice. Oncogene 2003, 22 (58), 9254-9264.
105. Mantena, S. K.; Meeran, S. M.; Elmets, C. A.; Katiyar, S. K. Orally administered green tea polyphenols prevent ultraviolet radiation-induced skin cancer in mice through activation of cytotoxic T cells and inhibition of angiogenesis in tumors. J. Nutr. 2005, 135(12), 2871-2877.
106. Zykova, T. A.; Zhang, Y.; Zhu, F.; Bode, A. M.; Dong, Z. The signal transduction networks required for phosphorylation of STAT1 at Ser727 in mouse epidermal JB6 cells in the UVB response and inhibitory mechanisms of tea polyphenols. Carcinogenesis 2005, 26 (2), 331-342.
107. Xia, J.; Song, X.; Bi, Z.; Chu, W.; Wan, Y. UV-induced NF-kappaB activation and expression of IL-6 is attenuated by (-)-epigallocatechin-3- gallate in cultured human keratinocytes in vitro. Int. J. Mol. Med. 2005, 16 (5), 943-950.
108. Song, X. Z.; Bi, Z. G.; Xu, A. E. Green tea polyphenol epigallocatechin-3-gallate inhibits the expression of nitric oxide synthase and generation of nitric oxide induced by ultraviolet B in HaCaT cells. Chin. Med. J. (Engl) 2006, 119(4), 282-287.
109. De Haes, P.; Garmyn, M.; Verstuyf, A.; De Clercq, P.; Vandewalle, M.; Degreef, H.; Vantieghem, K.; Bouillon, R.; Segaert, S. 1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. J. Photochem. Photobiol. B 2005, 78 (2), 141-148.
110. De Haes, P.; Garmyn, M.; Degreef, H.; Vantieghem, K.; Bouillon, R.; Segaert, S. 1,25-Dihydroxyvitamin D3 inhibits ultraviolet B-induced apoptosis, Jun kinase activation, and interleukin-6 production in primary human keratinocytes. J. Cell Biochem. 2003, 89 (4), 663-673.
111. De Haes, P.; Garmyn, M.; Verstuyf, A.; De Clercq, P.; Vandewalle, M.; Vantieghem, K.; Degreef, H.; Bouillon, R.; Segaert, S. Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB. Arch. Dermatol. Res. 2004, 295(12), 527-534.
112. Zhu, M.; Zhang, Y.; Cooper, S.; Sikorski, E.; Rohwer, J.; Bowden, G. T. Phase II enzyme inducer, sulforaphane, inhibits UVB-induced AP-1 activation in human keratinocytes by a novel mechanism. Mol. Carcinog. 2004, 41 (3), 179-186.
113. Afaq, F.; Adhami, V. M.; Ahmad, N. Prevention of short-term ultraviolet B radiation-mediated damages by resveratrol in SKH-1 hairless mice. Toxicol. Appl. Pharmacol. 2003, 186(1), 28-37.
114. Reagan-Shaw, S.; Afaq, F.; Aziz, M. H.; Ahmad, N. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin. Oncogene 2004, 23 (30), 5151-5160.
115. Aziz, M. H.; Reagan-Shaw, S.; Wu, J.; Longley, B. J.; Ahmad, N. Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease? FASEB J. 2005, 19 (9), 1193-1195.
116. Mittal, A.; Elmets, C. A.; Katiyar, S. K. Dietary feeding of proanthocyanidins from grape seeds prevents photocarcinogenesis in SKH-1 hairless mice: relationship to decreased fat and lipid peroxidation. Carcinogenesis 2003, 24 (8), 1379-1388.
117. Mallikarjuna, G.; Dhanalakshmi, S.; Singh, R. P.; Agarwal, C.; Agarwal, R. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res. 2004, 64 (17), 6349-6356.
118. Gu, M.; Dhanalakshmi, S.; Mohan, S.; Singh, R. P.; Agarwal, R. Silibinin inhibits ultraviolet B radiation-induced mitogenic and survival signaling, and associated biological responses in SKH-1 mouse skin. Carcinogenesis 2005, 26 (8), 1404-1413.
119. Gu, M.; Dhanalakshmi, S.; Singh, R. P.; Agarwal, R. Dietary feeding of silibinin prevents early biomarkers of UVB radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis. Cancer Epidemiol. Biomarkers Prev. 2005, 14 (5), 1344-1349.
120. Feng, R.; Bowman, L. L.; Lu, Y.; Leonard, S. S.; Shi, X.; Jiang, B. H.; Castranova, V.; Vallyathan, V.; Ding, M. Blackberry extracts inhibit activating protein 1 activation and cell transformation by perturbing the mitogenic signaling pathway. Nutr. Cancer 2004, 50 (1), 80-89.
121. Ding, M.; Feng, R.; Wang, S. Y.; Bowman, L.; Lu, Y.; Qian, Y.; Castranova, V.; Jiang, B. H.; Shi, X. Cyanidin-3-glucoside, a natural product derived from blackberry, exhibits chemopreventive and chemotherapeutic activity. J. Biol. Chem. 2006, 281, 17359-17368.
122. Wang, S. Y.; Feng, R.; Bowman, L.; Penhallegon, R.; Ding, M.; Lu, Y. Antioxidant activity in lingonberries (Vaccinium vitis-idaea L.) and its inhibitory effect on activator protein-1, nuclear factor-kappaB, and mitogen-activated protein kinases activation. J. Agric. Food Chem. 2005, 53 (8), 3156-3166.
123. Wang, S. Y.; Feng, R.; Lu, Y.; Bowman, L.; Ding, M. Inhibitory effect on activator protein-1, nuclear factor-kappaB, and cell transformation by extracts of strawberries (Fragaria x ananassa Duch.). J. Agric. Food Chem. 2005, 53 (10), 4187-4193.